Market closedNon-fractional

ImmunoPrecise Antibodies/IPA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.

Ticker

IPA

Sector

Healthcare

Trading on

NASDAQ

Industry

Life Sciences Tools and Services

Headquarters

Victoria, Canada

Employees

102

IPA Metrics

BasicAdvanced
$19M
Market cap
-
P/E ratio
-$0.41
EPS
0.36
Beta
-
Dividend rate
$19M
0.36
1.657
1.176
25.338
28.887
-10.99%
-25.72%
1.454
0.53
8.04
-7.534
16.75%
-48.35%
11.29%
38.20%

What the Analysts think about IPA

Analyst Ratings

Majority rating from 2 analysts.
Buy

IPA Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 10.00%
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
-$0.21
-$0.14
-$0.10
-$0.11
-
Expected
-$0.17
-$0.21
-$0.13
-$0.10
-$0.12
Surprise
23.53%
-31.71%
-23.08%
10.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for ImmunoPrecise Antibodies stock?

ImmunoPrecise Antibodies (IPA) has a market cap of $19M as of July 06, 2024.

What is the P/E ratio for ImmunoPrecise Antibodies stock?

The price to earnings (P/E) ratio for ImmunoPrecise Antibodies (IPA) stock is 0 as of July 06, 2024.

Does ImmunoPrecise Antibodies stock pay dividends?

No, ImmunoPrecise Antibodies (IPA) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next ImmunoPrecise Antibodies dividend payment date?

ImmunoPrecise Antibodies (IPA) stock does not pay dividends to its shareholders.

What is the beta indicator for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies (IPA) has a beta rating of 0.36. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell ImmunoPrecise Antibodies stock

Buy or sell ImmunoPrecise Antibodies stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing